Tag: vagus nerve stimulation

LivaNova RECOVER design published

New study shows significant positive impact of vagus nerve stimulation therapy...

Adding vagus nerve stimulation (VNS) therapy to treatment as usual (TAU) has been demonstrated to improve outcomes in patients with treatment-resistant bipolar depression (TRBD)....
Peter Staats COVID-19 nVNS

Non-invasive vagus nerve stimulation may provide clinical benefit to patients with...

An article accepted into the journal Neuromodulation has concluded that, based on two case reports, non-invasive vagus nerve stimulation (nVNS) might provide clinical benefits...

Cervical non-invasive vagus nerve stimulation effectively relieves pain in migraine sufferers

A recent meta-analysis demonstrated that cervical non-invasive vagus nerve stimulation (nVNS) is a safe and effective method for acute pain relief in migraine and...
LivaNova RECOVER design published

LivaNova collaborates with Verily to fuel research into vagus nerve stimulation...

LivaNova has announced a research collaboration with Verily, an Alphabet company, to capture measures of depression within its RECOVER clinical study, which is evaluating...

News from NANS: First long-term vagus nerve stimulation implant in mice

Data showing the effective use of a long-term vagus nerve implant in mice have been presented at the North American Neuromodulation Society’s (NANS) annual...
RECOVER

LivaNova enrols first patient in RECOVER clinical study

LivaNova has announced the first patient enrolled in their RECOVER trial, a prospective, multi-centre, randomised controlled blinded trial demonstrating the safety and effectiveness of...
LivaNova RECOVER design published

CMS trial clearance for LivaNova’s vagus nerve stimulation therapy for treatment-resistant...

LivaNova has recognised that the US Centers for Medicare & Medicaid Services (CMS) finalised its National Coverage Determination (NCD) for the LivaNova vagus nerve...

FDA approves SenTiva device for treatment of epilepsy

LivaNova has received US Food and Drug Administration (FDA) approvals for its latest Vagus Nerve Stimulation (VNS) Therapy System, which consists of the SenTiva implantable...

LivaNova’s VNS Therapy receives FDA approval for expanded MRI labelling

  LivaNova’s latest vagus nerve stimulation (VNS Therapy) system has received US Food and Drug Administration (FDA) approval for expanded magnetic resonance imaging labelling. According...